Open AccessOutcome of Myeloma Patients with COVID-19 on Active Lenalidomide-Based Therapy: Does Lenalidomide Protect From Severe COVID-19?
Author(s) -
Imran K Tailor,
Nawal F Alshehry,
Syed Ziauddin A. Zaidi,
Mohammed Marei,
Ibraheem Motabi,
Mansour Alfayez,
Syed Altaf
Publication year - 2020
Publication title -
hematology/oncology and stem cell therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.666
H-Index - 22
eISSN - 1658-3876
pISSN - 2589-0646
DOI - 10.1016/j.hemonc.2020.08.002
Subject(s) - lenalidomide , covid-19 , multiple myeloma , medicine , virology , oncology , disease , infectious disease (medical specialty) , outbreak
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom